Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
220.36
-0.14 (-0.06%)
At close: Dec 5, 2025, 4:00 PM EST
219.64
-0.72 (-0.33%)
After-hours: Dec 5, 2025, 7:16 PM EST
Cidara Therapeutics Employees
Cidara Therapeutics had 38 employees as of December 31, 2024. The number of employees decreased by 31 or -44.93% compared to the previous year.
Employees
38
Change (1Y)
-31
Growth (1Y)
-44.93%
Revenue / Employee
n/a
Profits / Employee
-$4,861,526
Market Cap
6.93B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CDTX News
- 12 days ago - Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations - GlobeNewsWire
- 16 days ago - Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer - The Motley Fool
- 16 days ago - Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. - The Motley Fool
- 17 days ago - Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025 - Forbes
- 19 days ago - This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover - The Motley Fool
- 19 days ago - Merck expects over $5 billion commercial opportunity from Cidara's flu drug - Reuters
- 19 days ago - Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
- 20 days ago - Cidara Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cidara Therapeutics, Inc. - CDTX - Business Wire